Vogenx Inc. (VOGX) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Vogenx Inc. (VOGX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $239.2M, listed on NASDAQ, employing roughly 4 people, carrying a beta of 0.00 to the broader market. Vogenx is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia (PBH) and gastroparesis. Led by James Green, public since 2026-08-12.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for VOGX as of 2026-10-16; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →